ID: MRFR/HC/8136-HCR | February 2021 | Region: Global | 153 Pages
Table of Contents
1. EXECUTIVE SUMMARY
1.1. Market Attractiveness Analysis
1.1.1. Global Angioplasty Balloons Market, by Product Type
1.1.2. Global Angioplasty Balloons Market, by End User
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.3. Research Objective
2.4. List of Assumptions & Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Breakdown of Primary Respondents
3.5. Forecasting Techniques
3.6. Research Methodology for Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porterβs Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.2.1. R&D and Designing
5.2.2. Manufacturing
5.2.3. Distribution and Sales
5.2.4. Post Sales Services
5.3. Impact of COVID-19 on Angioplasty Balloons Market
5.3.1. Impact on Raw Material Supply
5.3.2. Impact on Growth Rate
5.3.3. Impact on R&D and Product Pipeline
5.3.4. Impact on Regions and Countries
5.3.5. Opportunities and Threats
6. GLOBAL ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE
6.1. Overview
6.2. Normal Balloons
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
6.3. Cutting Balloons
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
6.4. Drug Eluting Balloons
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
6.5. Scoring Balloons
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
7. GLOBAL ANGIOPLASTY BALLOONS MARKET, BY APPLICATION
7.1. Overview
7.2. Coronary Artery Disease
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
7.3. Peripheral Artery Disease
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
8. GLOBAL ANGIOPLASTY BALLOONS MARKET, BY END USER
8.1. Overview
8.2. Hospitals
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
8.3. Cardiac Catheterization Laboratories
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
8.4. Ambulatory Surgical Centers
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
8.5. Others
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
9. GLOBAL ANGIOPLASTY BALLOONS MARKET, BY REGION
9.1. Overview
9.2. Americas
9.2.1. North America
9.2.1.1. US
9.2.1.2. Canada
9.2.2. Latin America
9.3. Europe
9.3.1. Western Europe
9.3.1.1. Germany
9.3.1.2. France
9.3.1.3. UK
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Western Europe
9.3.2. Eastern Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific
9.5. Middle East & Africa
9.5.1. Middle East
9.5.2. Africa
10. COMPANY LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Company Share Analysis
10.4. Competitor Dashboard
10.5. Major Growth Strategy in the Global Angioplasty Balloons Market
10.6. Competitive Benchmarking
10.7. Leading Player in terms of Number of Developments in the Global Angioplasty Balloons Market
10.8. Key Developments & Growth Strategies
10.8.1. New Product Launch
10.8.2. Merger & Acquisition
10.8.3. Joint Ventures
10.9. Major Players Financial Matrix & Market Ratio
10.9.1. Sales & Operating Income 2019
10.9.2. Major Players R&D Expenditure 2019
11. COMPANY PROFILES
11.1. Biotronik SE & Co. KG
11.1.1. Company Overview
11.1.2. Products/Services Offered
11.1.3. Financial Overview
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Boston Scientific Corporation
11.3. C.R. Bard (BD)
11.4. Cook
11.5. Cordis (Cardinal Health)
11.6. Endocor
11.7. Koninklijke Philips N.V.
11.8. Medtronic
11.9. Terumo Medical Corporation
11.10. Abbott
11.11. B. Braun Melsungen AG
11.12. Others
12. APPENDIX
12.1. References
12.2. Related Reports
β
LIST OF TABLES
TABLE 1 GLOBAL ANGIOPLASTY BALLOONS MARKET SYNOPSIS, 2020β2027
TABLE 2 GLOBAL ANGIOPLASTY BALLOONS MARKET ESTIMATES & FORECAST, 2020β2027 (USD MILLION)
TABLE 3 GLOBAL ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020β2027 (USD MILLION)
TABLE 4 GLOBAL ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020β2027 (USD MILLION)
TABLE 5 GLOBAL ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020β2027 (USD MILLION)
TABLE 6 GLOBAL ANGIOPLASTY BALLOONS MARKET, BY REGION, 2020β2027 (USD MILLION)
TABLE 7 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020β2027 (USD MILLION)
TABLE 8 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020β2027 (USD MILLION)
TABLE 9 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020β2027 (USD MILLION)
TABLE 10 US: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020β2027 (USD MILLION)
TABLE 11 US: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020β2027 (USD MILLION)
TABLE 12 US: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020β2027 (USD MILLION)
TABLE 13 CANADA: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020β2027 (USD MILLION)
TABLE 14 CANADA: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020β2027 (USD MILLION)
TABLE 15 CANADA: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020β2027 (USD MILLION)
TABLE 16 LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020β2027 (USD MILLION)
TABLE 17 LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020β2027 (USD MILLION)
TABLE 18 LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020β2027 (USD MILLION)
TABLE 19 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020β2027 (USD MILLION)
TABLE 20 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020β2027 (USD MILLION)
TABLE 21 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020β2027 (USD MILLION)
TABLE 22 WESTERN EUROPE: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020β2027 (USD MILLION)
TABLE 23 WESTERN EUROPE: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020β2027 (USD MILLION)
TABLE 24 WESTERN EUROPE: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020β2027 (USD MILLION)
TABLE 25 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020β2027 (USD MILLION)
TABLE 26 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020β2027 (USD MILLION)
TABLE 27 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020β2027 (USD MILLION)
TABLE 28 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020β2027 (USD MILLION)
TABLE 29 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020β2027 (USD MILLION)
TABLE 30 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020β2027 (USD MILLION)
TABLE 31 UK: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020β2027 (USD MILLION)
TABLE 32 UK: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020β2027 (USD MILLION)
TABLE 33 UK: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020β2027 (USD MILLION)
TABLE 34 ITALY: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020β2027 (USD MILLION)
TABLE 35 ITALY: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020β2027 (USD MILLION)
TABLE 36 ITALY: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020β2027 (USD MILLION)
TABLE 37 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020β2027 (USD MILLION)
TABLE 38 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020β2027 (USD MILLION)
TABLE 39 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020β2027 (USD MILLION)
TABLE 40 REST OF WESTERN EUROPE: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020β2027 (USD MILLION)
TABLE 41 REST OF WESTERN EUROPE: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020β2027 (USD MILLION)
TABLE 42 REST OF WESTERN EUROPE: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020β2027 (USD MILLION)
TABLE 43 EASTERN EUROPE: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020β2027 (USD MILLION)
TABLE 44 EASTERN EUROPE: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020β2027 (USD MILLION)
TABLE 45 EASTERN EUROPE: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020β2027 (USD MILLION)
TABLE 46 ASIA-PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020β2027 (USD MILLION)
TABLE 47 ASIA-PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020β2027 (USD MILLION)
TABLE 48 ASIA-PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020β2027 (USD MILLION)
TABLE 49 JAPAN: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020β2027 (USD MILLION)
TABLE 50 JAPAN: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020β2027 (USD MILLION)
TABLE 51 JAPAN: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020β2027 (USD MILLION)
TABLE 52 CHINA: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020β2027 (USD MILLION)
TABLE 53 CHINA: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020β2027 (USD MILLION)
TABLE 54 CHINA: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020β2027 (USD MILLION)
TABLE 55 INDIA: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020β2027 (USD MILLION)
TABLE 56 INDIA: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020β2027 (USD MILLION)
TABLE 57 INDIA: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020β2027 (USD MILLION)
TABLE 58 AUSTRALIA: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020β2027 (USD MILLION)
TABLE 59 AUSTRALIA: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020β2027 (USD MILLION)
TABLE 60 AUSTRALIA: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020β2027 (USD MILLION)
TABLE 61 SOUTH KOREA: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020β2027 (USD MILLION)
TABLE 62 SOUTH KOREA: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020β2027 (USD MILLION)
TABLE 63 SOUTH KOREA: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020β2027 (USD MILLION)
TABLE 64 REST OF ASIA-PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020β2027 (USD MILLION)
TABLE 65 REST OF ASIA-PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020β2027 (USD MILLION)
TABLE 66 REST OF ASIA-PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020β2027 (USD MILLION)
TABLE 67 MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020β2027 (USD MILLION)
TABLE 68 MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020β2027 (USD MILLION)
TABLE 69 MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020β2027 (USD MILLION)
TABLE 70 MIDDLE EAST: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020β2027 (USD MILLION)
TABLE 71 MIDDLE EAST: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020β2027 (USD MILLION)
TABLE 72 MIDDLE EAST: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020β2027 (USD MILLION)
TABLE 73 AFRICA: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020β2027 (USD MILLION)
TABLE 74 AFRICA: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020β2027 (USD MILLION)
TABLE 75 AFRICA: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020β2027 (USD MILLION)
β
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ANGIOPLASTY BALLOONS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ANGIOPLASTY BALLOONS MARKET
FIGURE 4 GLOBAL ANGIOPLASTY BALLOONS MARKET SHARE, BY PRODUCT TYPE, 2019 (%)
FIGURE 5 GLOBAL ANGIOPLASTY BALLOONS MARKET SHARE, BY APPLICATION, 2019 (%)
FIGURE 6 GLOBAL ANGIOPLASTY BALLOONS MARKET SHARE, BY END USER, 2019 (%)
FIGURE 7 GLOBAL ANGIOPLASTY BALLOONS MARKET SHARE, BY REGION, 2019 (%)
FIGURE 8 AMERICAS: ANGIOPLASTY BALLOONS MARKET SHARE BY REGION, 2019 (%)
FIGURE 9 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET SHARE, BY COUNTRY, 2019 (%)
FIGURE 10 EUROPE: ANGIOPLASTY BALLOONS MARKET SHARE, BY REGION, 2019 (%)
FIGURE 11 WESTERN EUROPE: ANGIOPLASTY BALLOONS MARKET SHARE, BY COUNTRY, 2019 (%)
FIGURE 12 ASIA-PACIFIC: ANGIOPLASTY BALLOONS MARKET SHARE, BY COUNTRY, 2019 (%)
FIGURE 13 MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET SHARE, BY REGION, 2019 (%)
FIGURE 14 GLOBAL ANGIOPLASTY BALLOONS MARKET: COMPANY SHARE ANALYSIS, 2019 (%)
FIGURE 15 BIOTRONIK SE & CO. KG: KEY FINANCIALS
FIGURE 16 BIOTRONIK SE & CO. KG: SEGMENTAL REVENUE
FIGURE 17 BIOTRONIK SE & CO. KG: REGIONAL REVENUE
FIGURE 18 BOSTON SCIENTIFIC CORPORATION.: KEY FINANCIALS
FIGURE 19 BOSTON SCIENTIFIC CORPORATION.: SEGMENTAL REVENUE
FIGURE 20 BOSTON SCIENTIFIC CORPORATION.: REGIONAL REVENUE
FIGURE 21 C.R. BARD (BD): KEY FINANCIALS
FIGURE 22 C.R. BARD (BD): SEGMENTAL REVENUE
FIGURE 23 C.R. BARD (BD): REGIONAL REVENUE
FIGURE 24 COOK: KEY FINANCIALS
FIGURE 25 COOK: SEGMENTAL REVENUE
FIGURE 26 COOK: REGIONAL REVENUE
FIGURE 27 CORDIS (CARDINAL HEALTH): KEY FINANCIALS
FIGURE 28 CORDIS (CARDINAL HEALTH): SEGMENTAL REVENUE
FIGURE 29 CORDIS (CARDINAL HEALTH): REGIONAL REVENUE
FIGURE 30 ENDOCOR: KEY FINANCIALS
FIGURE 31 ENDOCOR: SEGMENTAL REVENUE
FIGURE 32 ENDOCOR: REGIONAL REVENUE
FIGURE 33 KONINKLIJKE PHILIPS N.V.: KEY FINANCIALS
FIGURE 34 KONINKLIJKE PHILIPS N.V.: SEGMENTAL REVENUE
FIGURE 35 KONINKLIJKE PHILIPS N.V.: REGIONAL REVENUE
FIGURE 36 MEDTRONIC: KEY FINANCIALS
FIGURE 37 MEDTRONIC: SEGMENTAL REVENUE
FIGURE 38 MEDTRONIC: REGIONAL REVENUE
FIGURE 39 TERUMO MEDICAL CORPORATION: KEY FINANCIALS
FIGURE 40 TERUMO MEDICAL CORPORATION: SEGMENTAL REVENUE
FIGURE 41 TERUMO MEDICAL CORPORATION: REGIONAL REVENUE
FIGURE 42 ABBOTT: KEY FINANCIALS
FIGURE 43 ABBOTT: SEGMENTAL REVENUE
FIGURE 44 ABBOTT: REGIONAL REVENUE
FIGURE 45 B. BRAUN MELSUNGEN AG: KEY FINANCIALS
FIGURE 46 B. BRAUN MELSUNGEN AG: SEGMENTAL REVENUE
FIGURE 47 B. BRAUN MELSUNGEN AG: REGIONAL REVENUE
$3457.35 Million
5.01%
North America
2020-2027
Angioplasty Balloons Market size is anticipated to hold a value of USD 3457.35 Million by 2027 and is expected to register a CAGR of 5.01% during the assessment period of 2020 to 2027.
Market Synopsis
With increasing cases of artery diseases, balloon angioplasty has become the method of choice to treat patients suffering from coronary and peripheral artery diseases. Cardiac diseases are rising at an enormous rate, and this calls for precise treatment alternatives with high success rates. Each year cardiovascular diseases cause 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU).
Market Influencer
The companies operating in the angioplasty balloons market are focused on developing high-quality products incorporating cutting edge technologies. Also, established players are investing in clinical trials for the differentiation of products. Such initiatives promise a massive level of growth in the market. In addition to that, the increasing trend of minimally invasive procedures for the treatment of peripheral and coronary artery ailments is set to boost the market growth over the forecast period.
Market Drivers
Market Restraints
Segmentation
By Product Type
By Application
By End-User
By Region
Key Players
Report Attribute/Metric | Details |
---|---|
Market Size | 2027: USD 3457.35 Million |
CAGR | 5.01% (2020-2027) |
Base Year | 2019 |
Forecast Period | 2020-2027 |
Historical Data | 2018 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Product Type, Application and End User |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | B. Braun Melsungen AG (Germany), Abbott (US), Biotronik SE & Co. KG (Germany), C.R. Bard (BD) (US), Boston Scientific Corporation (US), Cook (US), Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), Terumo Medical Corporation (Japan), Cordis (Cardinal Health) (US), and Endocor (Germany). |
Key Market Opportunities | Increasing Trend of Minimally Invasive Procedures for the Treatment of Peripheral and Coronary Artery Ailments is set to boost the Market Growth over the Forecast Period. |
Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
The upswing in cardiac ailment is likely to spur the market in the impending period.
A 5% CAGR is estimated to enable the market to achieve high growth in the future.
A USD 3457.35 Million is estimated to prompt positive growth in the market.
The Americas' regional market is estimated to be in the spotlight in the upcoming period.
Boston Scientific Corporation (US), Cordis (Cardinal Health) (US), Cook (US), Biotronik SE & Co. KG (Germany), Koninklijke Philips N.V. (Netherlands)are inducing significant growth in the market.